Nessuna corrispondenza per “”
Suggerimento: Prova un simbolo valido o un nome di azienda specifico per risultati pertinenti
Il mio portafoglio
Panoramica del mercato
Convertitore di valuta
Classifiche e foto
Italia markets open in 6 hours 23 minutes
Laboratory Corporation of America Holdings (LH)
NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
Alla chiusura: 4:00PM EST
12 reazioni su Conversazione su $LH
Accedi per pubblicare un messaggio.
Reazioni più popolari
OPKO Health, Inc.
Earnings report coming tomorrow for $LH. Expecting a blowout quarter, raising the whole sector with it.
Target Raised by Mizuho Securities Buy USD 215 » USD 234
Target Raised by Wells Fargo Overweight USD 225 » USD 260
Meanwhile $DGX & $LH... Let’s just say I’m glad I sold DGX and went on $OPK. I’m already close to 100% return in about a month
IMHO, the recent drop to the $124 level just offered an opportunity for a long term BUY. They are growing fast and I don't think they will be this cheap again.
So $OPK up 144% since last month. How is $DGX & $LH doing..?
Demise of Theranos no great surprise, but removes a potential long term negative.
Laboratory Corporation of America® Holdings (LabCorp®) (LH) today announced it will participate at the 2016 Credit Suisse Nov-7th-Healthcare Conference.
LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET).
As investors are you at all concerned with the terrible back office at LCA? I've been fighting them through my insurance company for six months on a service that was paid back in January. Labcorp was paid on April 26, 2016 by my insurance but I continue to be billed, in full, for the service. I call my insurance, they confirm payment, then call Labcorp. Labcorp says they will put my billing on hold and will look into it. Then a couple of months later without comment from Labcorp I get another ever escalating invoice/collection notice. This is extremely poor customer service. It seems like my only recourse is to hire an attorney that I can not afford. Maybe there are others out there with the same problem. If so we could start a class action against LCA.
S&P Capital NEW LH PRICE TARGET: 12-month target of $155, 15.8X our '17 EPS estimate.
This multiple is a premium to peers, justified by our above average sales growth outlook.
***We raise our '16 and '17 EPS estimates by $0.02 and $0.10 to $8.81 and $9.79.
LH reported Q3 operating EPS of $2.25 vs $2.07, $0.04. Q3 sales increased 4.5%.
We expect 10.8% sales growth in '16 aided by pricing improvements due to growth in esoteric test volumes.
With Theranos OUT--there is LESS Competition!
Last SPLIT was 2002 (2 for 1) -STILL ONLY 100Million Shares outstanding.
IMHO_ IF another SPLIT is announced-it could be around Dec. 9th--which would be ex-div. date (if Div. was forthcoming)
IMHO- Theranos Departure from Lab Diagnostics-has helped LH icrease Market Share....
$LH has the testing job for the country not this pump and dump.
Olio di cocco: come assumerlo per dimagrire
Piazza Affari parte in quarta, CNH Industrial spicca il volo
Claire Miller ha ucciso Helen a soli 14 anni
© 2021 Verizon Media. Tutti i diritti riservati.
Esclusione di responsabilità sui dati
I nostri annunci